Integrated Care for Cancer Patients; Developing, Implementing and Testing a Programme to Improve Integrated Care

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2007 by Radboud University.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Radboud University
ClinicalTrials.gov Identifier:
NCT00135980
First received: August 25, 2005
Last updated: February 28, 2007
Last verified: February 2007
  Purpose

The purpose of this study is to compose, implement and evaluate a programme to improve the quality of integrated care for patients with cancer.

Literature will be searched for components of integrated care programmes. On the basis of evidence based multi-disciplinary guidelines and literature on integrated care programmes, a set of indicators will be composed. This set will be measured in 6 hospitals on patients with non-small-cell-lung cancer. In two hospitals, an integrated care programme will be implemented and effects on processes and outcomes of care will be measured.


Condition Intervention
Neoplasms
Behavioral: professional audit and feedback
Behavioral: integrated care programmes

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Integrated Care for Cancer Patients

Further study details as provided by Radboud University:

Primary Outcome Measures:
  • guideline adherence

Secondary Outcome Measures:
  • hospitalization
  • satisfaction
  • quality of life

Estimated Enrollment: 300
Study Start Date: August 2004
Estimated Study Completion Date: July 2007
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Each new patient that visits the lung specialist in 6 hospitals in the east part of Holland, in the period from September 2004 till March 2005

Exclusion Criteria:

  • Mortality
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00135980

Locations
Netherlands
Rijnstate Hospital
Arnhem, Netherlands
MaasHospital Pantein
Boxmeer, Netherlands
Slingeland Hosptital
Doetinchem, Netherlands
Gelderse Vallei Hospital
Ede, Netherlands
CWZ Hospital
Nijmegen, Netherlands
Radboud University Medical Centre
Nijmegen, Netherlands
Sponsors and Collaborators
Radboud University
Investigators
Principal Investigator: Rosella Hermens, MSc,PhD Centre for Quality of Care Research, Radboud University Nijmegen Medical Centre
Study Director: Hub Wollersheim, MD,PhD Centre for Quality of Care Research, Radboud University Medical Centre
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00135980     History of Changes
Other Study ID Numbers: PACT-study M2100  M2100 
Study First Received: August 25, 2005
Last Updated: February 28, 2007

ClinicalTrials.gov processed this record on January 19, 2017